Lock in a narrative that actually lands with medtech investors. You’ll tighten your founder story, articulate the clinical problem you’re solving, and translate it into a clear, 10–15 slide deck investors can skim in two minutes and still remember.

You’ll walk away with:

• Sharpened founder + company narrative you can use in pitches, emails, and on your site.

• Revised deck outline (or updated deck) that follows a proven, investor‑friendly structure.

• Clear talking points for “why this problem, why now, and why you.”

Shift from “random intros” to a focused investor pipeline. You’ll map the right angels and funds, set up a simple tracking system, and develop warm intro requests, cold emails, and forwardable blurbs you can send at scale without feeling spammy.

You’ll walk away with:

• Prioritized list of target angels, funds, and connectors tailored to your round.

• Lightweight system to track outreach, meetings, and follow‑ups.

Tested scripts for warm intros, cold outbound, and a forwardable blurb champions can use to pitch you.

Stop slow‑rolling your raise and start running a deliberate sprint. You’ll learn how to stack investor meetings, create urgency without sounding desperate, and move conversations from first call to real interest using a simple, trackable process.

You’ll walk away with:

• 1-2 month fundraising sprint plan with clear weekly activity targets.

• Simple pipeline view so you always know where each investor sits and what happens next.

• Meeting framework and follow‑up cadence that keeps momentum moving toward term sheets.

Make it easy for investors to understand who you are and why you’re worth a meeting. You’ll upgrade your LinkedIn/profile copy, sharpen your website narrative, and build a 4–8 week content plan that supports your raise and keeps you top‑of‑mind with the people writing checks.

You’ll walk away with:

• Updated LinkedIn/profile copy and a punchy “who we are / what we do” for your website.

• 3–5 ready‑to‑publish posts that highlight your problem, traction, and raise.

• Simple content calendar that runs alongside your sprint and amplifies your investor outreach.

This cohort is designed for medical device and health technology CEOs who are either raising their first meaningful round or have raised before but are struggling to get traction in the current environment. If you have a product, a clear clinical problem, and at least some early traction, you’re a great fit.

Plan on 3–4 hours per week. That includes two 60–90 minute live sessions plus time to work on your assignments. The idea is that everything you do in the course directly supports your active or upcoming raise, not extra “homework” that sits on a shelf.

You’ll get the most value if you’re actively raising or planning to kick off a round in the next 3–6 months. The frameworks still apply if you’re earlier, but all the sessions and assignments are geared toward founders who want investor meetings on the calendar soon, not “someday.”

Yes, as long as you’re building a medtech company that could reasonably raise from institutional or professional investors (angels, family offices, early‑stage funds). The narrative, outbound, and brand systems are geography‑agnostic, and you can adapt the investor targeting and sprint planning to your local ecosystem.

Although it’s highly recommended that you attend live, all sessions are recorded and shared with course attendees, along with slides and templates. You’ll still be able to follow the assignments, and you can submit questions in advance so they’re addressed live even if you can’t join in real time.